{"legislative_session": "104th", "identifier": "SB1553", "title": "XYLAZINE-SCHED III-PENALTIES", "from_organization": "~{\"classification\": \"upper\"}", "classification": ["bill"], "subject": [], "abstracts": [{"note": "", "abstract": "Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards."}], "other_titles": [], "other_identifiers": [], "actions": [{"description": "Filed with Secretary by Sen. Patrick J. Joyce", "date": "2025-02-04", "organization_id": "~{\"classification\": \"upper\"}", "classification": ["filing"], "related_entities": []}, {"description": "First Reading", "date": "2025-02-04", "organization_id": "~{\"classification\": \"upper\"}", "classification": ["reading-1"], "related_entities": []}, {"description": "Referred to Assignments", "date": "2025-02-04", "organization_id": "~{\"classification\": \"upper\"}", "classification": [], "related_entities": []}, {"description": "Assigned to Criminal Law", "date": "2025-02-11", "organization_id": "~{\"classification\": \"upper\"}", "classification": ["referral-committee"], "related_entities": []}, {"description": "To Criminal Law Clear Compliance", "date": "2025-02-19", "organization_id": "~{\"classification\": \"upper\"}", "classification": [], "related_entities": []}, {"description": "Rule 2-10 Committee Deadline Established As April 4, 2025", "date": "2025-03-21", "organization_id": "~{\"classification\": \"upper\"}", "classification": [], "related_entities": []}], "sponsorships": [{"name": "Patrick J. Joyce", "classification": "primary", "entity_type": "person", "primary": true, "person_id": "~{\"chamber\": \"upper\", \"name\": \"Patrick J. Joyce\"}", "organization_id": null}], "related_bills": [], "versions": [{"note": "Introduced", "links": [{"url": "https://beta.ilga.gov/documents/legislation/104/SB/PDF/10400SB1553.pdf", "media_type": "application/pdf"}, {"url": "https://beta.ilga.gov/Legislation/BillStatus/FullText?LegDocId=200040&DocName=10400SB1553&DocNum=1553&DocTypeID=SB&LegID=160253&GAID=18&SessionID=114&SpecSess=&Session=&Print=1", "media_type": "text/html"}], "date": "", "classification": ""}], "documents": [], "citations": [], "sources": [{"url": "https://beta.ilga.gov/Legislation/BillStatus?DocNum=1553&GAID=18&DocTypeID=SB&LegId=160253&SessionID=114", "note": ""}], "extras": {}, "_id": "705351a8-172a-11f0-9eaa-86812f74cec2"}